Legal & General Group PLC Ampio Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.08 - $21.0 $1,214 - $318,801	-15,181 Closed	0 $0
Q2 2022 Aug 22, 2022	SELL	$0.16 - $0.47 $790 - $2,322	-4,942 Reduced 24.56%	15,181 $3,000
Q2 2021 Aug 12, 2021	BUY	$1.56 - $1.98 $31,391 - $39,843	20,123 New	20,123 $34,000
Q3 2019 Nov 13, 2019	SELL	$0.38 - $0.52 $4,483 - $6,135	-11,799 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$1.66 - $3.82 $19,586 - $45,072	11,799 New	11,799 $26,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.